1. Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care
- Author
-
Robert W. Gibson, Cecelia Calhoun, Marsha Treadwell, Norma Pugh, Allison A. King, Jane S. Hankins, Raymona H. Lawrence, Jeffrey Glassberg, Rita V Masese, Julie Kanter, and Matthew P. Smeltzer
- Subjects
Male ,Adult ,medicine.medical_specialty ,Adolescent ,Population ,Anemia, Sickle Cell ,Disease ,Young Adult ,Acute care ,Health care ,Humans ,Medicine ,education ,Original Investigation ,Quality of Health Care ,Response rate (survey) ,education.field_of_study ,business.industry ,Research ,Hematology ,General Medicine ,Emergency department ,Middle Aged ,United States ,Health equity ,Online Only ,Patient Satisfaction ,Family medicine ,Needs assessment ,Educational Status ,Female ,business - Abstract
Key Points Question What are the barriers to care experienced by adolescents and adults living with sickle cell disease in the United States? Findings This survey study conducted by the Sickle Cell Disease Implementation Consortium enrolled 440 adolescents and adults in 7 different states and found that most respondents were pleased with their usual care physicians but had negative experiences in acute care settings. Pain and the frequency of pain episodes were associated with patient-reported self-efficacy, further emphasizing the association of severe pain with poor outcomes in this population. Meaning A negative perception of care in the emergency department setting may be a barrier for seeking care among adolescents and adults living with sickle cell disease., Importance Sickle cell disease (SCD) is the most common inherited red blood cell disorder in the United States, and previous studies have shown that individuals with SCD are affected by multiple health disparities, including stigmatization, inequities in funding, and worse health outcomes, which may preclude their ability to access quality health care. This needs assessment was performed as part of the Sickle Cell Disease Implementation Consortium (SCDIC) to assess barriers to care that may be faced by individuals with SCD. Objective To assess the SCD-related medical care experience of adolescents and adults with SCD. Design, Setting, and Participants This one-time survey study evaluated pain interference, quality of health care, and self-efficacy of 440 adults and adolescents (aged 15 to 50 years) with SCD of all genotypes and assessed how these variables were associated with their perceptions of outpatient and emergency department (ED) care. The surveys were administered once during office visits by trained study coordinators at 7 of 8 SCDIC sites in 2018. Results The SCDIC sites did not report the number of individuals approached to participate in this study; thus, a response rate could not be calculated. In addition, respondents were not required to answer every question in the survey; thus, the response rate per question differed for each variable. Of 440 individuals with SCD, participants were primarily female (245 [55.7%]) and African American (428 [97.3%]) individuals, with a mean (SD) age of 27.8 (8.6) years. The majority of participants (306 of 435 [70.3%]) had hemoglobin SS or hemoglobin S β0-thalassemia. Most respondents (361 of 437 [82.6%]) reported access to nonacute (usual) SCD care, and the majority of respondents (382 of 413 [92.1%]) noted satisfaction with their usual care physician. Of 435 participants, 287 (66.0%) reported requiring an ED visit for acute pain in the previous year. Respondents were less pleased with their ED care than their usual care clinician, with approximately half (146 of 287 [50.9%]) being satisfied with or perceiving having adequate quality care in the ED. Participants also noted that when they experienced severe pain or clinician lack of empathy, this was associated with a negative quality of care. Age group was associated with ED satisfaction, with younger patients (, This survey study evaluates pain interference, quality of health care, and disease-specific self-efficacy to assess perceived barriers for seeking care among adults and adolescents with sickle cell disease..
- Published
- 2020
- Full Text
- View/download PDF